SYNLAB employs advanced diagnostic technologies to enhance patient care and improve health outcomes. The company specializes in a wide range of laboratory testing services, including routine and specialty tests, which are crucial for early detection, diagnosis, treatment monitoring, and post-treatment follow-up. With over 600 million laboratory tests conducted annually across more than 450 laboratories and 2,000 blood collection points, SYNLAB leverages its extensive network and expertise to provide reliable diagnostic information. This wealth of data, derived from small blood or tissue samples, plays a significant role in clinical decision-making, with over 65% of such decisions based on laboratory results.

In addition to its diagnostic capabilities, SYNLAB is committed to addressing global health challenges, such as antimicrobial resistance (AMR), which poses a significant threat to healthcare systems. The company emphasizes the importance of innovation in diagnostics, as highlighted by its focus on emerging technologies like liquid biopsy, which represents a new era in cancer care. By bringing together medical disciplines and international specialists, SYNLAB aims to lead in the field of diagnostics, ensuring high-quality services and actionable information for healthcare providers and patients alike.

Germany

SYNLAB Group is the leader in medical diagnostic services and specialty testing in Europe. The Group offers a full range of innovative and reliable medical diagnostics to patients, practising doctors, hospitals and clinics, governments and corporates.

SYNLAB operates in 30+ countries across four continents. More than 27,000 employees, including over 2,000 medical experts, contribute every day to the Group’s worldwide success.

SYNLAB

Company Details